“The iron chelating and radical scavenging actions of desferal and APO explains their ability to inhibit iron and 6‐hydroxydopamine (6‐OHDA)‐induced neurodegeneration and activation of redox‐sensitive transcription factor NF‐κB and the subsequent transactivation of promoters of genes involved in inflammatory cytokines.”